DySIS Medical (formerly Forth Photonics) designs, develops, manufactures and markets imaging systems for the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.

DySIS Medical helps medical practitioners improve patient care by incorporating advanced biophotonics and optical molecular imaging technologies to assist in early detection, diagnosis and monitoring.

Headquarters
UK

INVESTMENT DATE
April 2013

INVESTMENT THESIS
Venture-stage investment in medical technology

STATUS
Current

INDUSTRY
Imaging

STAGE CAPITAL TEAM
Aris Constantinides